
Why Sarepta Therapeutics, Genetics Stocks Just Surged
Shares of gene therapy companies — including Sarepta Therapeutics (SRPT), Avidity Biosciences (RNA) and Beam Therapeutics (BEAM) — got a lift Monday after Food and Drug Administration Commissioner Marty Makary laid out plans for a new accelerated approval …